We serve Chemical Name:2,8-Dichloroquinoxaline CAS:120258-69-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,8-Dichloroquinoxaline
CAS.NO:120258-69-7
Synonyms:Quinoxaline,2,8-dichloro;Quinoxaline, 2,8-dichloro-;2,8-dichloroquinoxaline;2,8-dichloro-quinoxaline
Molecular Formula:C8H4Cl2N2
Molecular Weight:199.037
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:279.2±35.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.671
PSA:25.78000
Exact Mass:197.975159
LogP:2.86
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Quinoxaline,2,8-dichloro chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,8-dichloro-quinoxaline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,8-dichloro-quinoxaline Use and application,2,8-dichloroquinoxaline technical grade,usp/ep/jp grade.
Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 2,8-Dichloroquinoxaline manufacturer However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them. 2,8-Dichloroquinoxaline supplier Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 2,8-Dichloroquinoxaline vendor However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them. 2,8-Dichloroquinoxaline factory Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.
